SIBN SI-BONE Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SIBN

Price (delayed)

$18.6

Market cap

$833.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.34

Enterprise value

$843.29M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 43

SI-BONE is a global leader in technology for the surgical treatment of sacropelvic disorders. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 4,000 ...

Highlights
The EPS rose by 39% YoY and by 13% QoQ
SI-BONE's net income has increased by 38% YoY and by 12% QoQ
SI-BONE's quick ratio has decreased by 10% QoQ but it has increased by 7% YoY
SI-BONE's debt has increased by 16% YoY
Sector: Healthcare
Industry: Medical Devices
Website: http://si-bone.com
Peers: EQT

Key stats

What are the main financial stats of SIBN

SIBN stock price

How has the SI-BONE stock price performed over time
Intraday
-1.12%
1 week
0.32%
1 month
-6.81%
1 year
30.43%
YTD
-5.68%
QTD
13.97%

Financial performance

How have SI-BONE's revenue and profit performed over time
Revenue
$213.6M
Gross profit
$169.87M
Operating income
-$17.75M
Net income
-$14.63M
Gross margin
79.5%
Net margin
-6.9%
SI-BONE's net margin has increased by 46% YoY and by 15% from the previous quarter
The company's operating margin rose by 44% YoY and by 14% QoQ
SI-BONE's net income has increased by 38% YoY and by 12% QoQ
The operating income is up by 36% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does SIBN's price correlate with its fundamentals

Growth

What is SI-BONE's growth rate over time

Valuation

What is SI-BONE stock price valuation
P/E
N/A
P/B
4.52
P/S
3.87
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.95
The EPS rose by 39% YoY and by 13% QoQ
SIBN's P/B is 17% above its last 4 quarters average of 3.9
The equity rose by 7% YoY
The P/S is 23% less than the 5-year quarterly average of 5.1 but 15% more than the last 4 quarters average of 3.4
The company's revenue rose by 15% YoY and by 3.6% QoQ

Efficiency

How efficient is SI-BONE business performance
The ROS rose by 49% YoY and by 17% QoQ
The ROIC has grown by 46% YoY and by 15% from the previous quarter
The ROE has grown by 42% YoY and by 15% from the previous quarter
SI-BONE's ROA has increased by 41% YoY and by 14% from the previous quarter

Dividends

What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SIBN.

Financial health

How did SI-BONE financials performed over time
SI-BONE's quick ratio has decreased by 10% QoQ but it has increased by 7% YoY
The company's total liabilities rose by 10% YoY and by 4.1% QoQ
SI-BONE's debt is 77% less than its equity
SI-BONE's debt has increased by 16% YoY
The equity rose by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.